The progression of obesity is accompanied by a chronic inflammatory process that involves both innate and acquired immunity. Natural killer T (NKT) cells recognize lipid antigens and are also distributed in adipose tissue. To examine the involvement of NKT cells in the development of obesity, C57BL/6 mice (wild type; WT), and two NKT-cell-deficient strains, Ja18 2/2 mice that lack the type I subset and CD1d 2/2 mice that lack both the type I and II subsets, were fed a high fat diet (HFD). CD1d 2/2 mice gained the least body weight with the least weight in perigonadal and brown adipose tissue as well as in the liver, compared to WT or Ja18 2/2 mice fed an HFD. Histologically, CD1d 2/2 mice had significantly smaller adipocytes and developed significantly milder hepatosteatosis than WT or Ja18 2/2 mice. The number of NK1.1 + TCRb + cells in adipose tissue increased when WT mice were fed an HFD and were mostly invariant Va14Ja18-negative. CD11b
Abstract
The progression of obesity is accompanied by a chronic inflammatory process that involves both innate and acquired immunity. Natural killer T (NKT) cells recognize lipid antigens and are also distributed in adipose tissue. To examine the involvement of NKT cells in the development of obesity, C57BL/6 mice (wild type; WT), and two NKT-cell-deficient strains, Ja18 2/2 mice that lack the type I subset and CD1d 2/2 mice that lack both the type I and II subsets, were fed a high fat diet (HFD). CD1d 2/2 mice gained the least body weight with the least weight in perigonadal and brown adipose tissue as well as in the liver, compared to WT or Ja18 2/2 mice fed an HFD. Histologically, CD1d 2/2 mice had significantly smaller adipocytes and developed significantly milder hepatosteatosis than WT or Ja18 2/2 mice. The number of NK1.1 + TCRb + cells in adipose tissue increased when WT mice were fed an HFD and were mostly invariant Va14Ja18-negative. CD11b
+ macrophages (Mw) were another major subset of cells in adipose tissue infiltrates, and they were divided into F4/80 high and F4/80 low cells. The F4/80 low -Mw subset in adipose tissue was increased in CD1d 2/2 mice, and this population likely played an anti-inflammatory role. Glucose intolerance and insulin resistance in CD1d 2/2 mice were not aggravated as in WT or Ja18 2/2 mice fed an HFD, likely due to a lower grade of inflammation and adiposity. Collectively, our findings provide evidence that type II NKT cells initiate inflammation in the liver and adipose tissue and exacerbate the course of obesity that leads to insulin resistance.
Introduction
Obesity is thought to progress with caloric excess under a chronic inflammatory process characterized by infiltration of adipose tissue by Mw and by cells of the adaptive immune system, such as T cells [1] [2] [3] . The inflammation in adipose tissue induces alterations in metabolic and endocrine functions of adipocytes, which leads to insulin resistance and various pathological responses [4, 5] . Recent studies by Nishimura et al revealed the active participation of CD8 + T cells in chronic inflammation in adipose tissue [6] . Moreover, CD4
+ Foxp3 + T cells with unique specificity have been detected in adipose tissue and were suggested to regulate the development of obesity by suppressing inflammatory responses [7] . Furthermore, additional findings showed that the transfer of CD4 + T cells from WT but not from T-cell receptor transgenic mice ameliorated the metabolic dysregulation in Rag-1 2/2 mice fed a high fat diet (HFD), which led to the idea that CD4
+ T cells play a suppressive role in diet-induced obesity (DIO) [8] . These studies have indicated that T cells that infiltrate adipose tissue are not just inert bystanders but are active modifiers of inflammation and thus either aggravate or ameliorate obesity.
Natural killer T (NKT) cells are a unique subset of T-lineage cells that recognize various lipid antigens in the context of CD1d molecules [9] . Among lipid ligands, a-galactosylceramide (aGalCer) is the prototype ligand [10] that can stimulate NKT cells to promptly produce large amounts of various cytokines and chemokines and also demonstrate cytocidal activity [11] . Endogenous ligands can also stimulate NKT cells to perform their innate effector functions [12] . Moreover, NKT cells localize to the liver [13] , where lipid metabolism is active, and in adipose tissue [14] , another location for lipid metabolism with endocrine functions. These considerations led us to suggest that, NKT cells might play a role in a disease that involves abnormal lipid metabolism or lipid-related inflammation. Indeed, several research groups including our team have demonstrated that NKT cells accelerate atherogenesis in a mouse model of atherosclerosis [15] [16] [17] 
Materials and Methods

Mice
Male and female 8-week-old C57BL/6 (B6; Nippon SLC, Shizuoka, Japan), B6.CD1d 2/2 [20] , and B6.Ja18 2/2 [21] mice were used. Mice were maintained on food and water ad libitum until they reached the desired weight (20-24 g) or age (8 wk) under specific pathogen-free conditions. All experiments were approved by the Committees of Animal Experimentation at Hokkaido University (permit number: #09-0022) and Kitasato University (permit number: #2011 105).
Diet-induced obesity
Mice were fed either regular chow as a standard fat diet (SFD; Nihon Nosan: fat 4.3%, cholesterol 0.03%, protein 18.3%, carbohydrate 58.3%) or an HFD (CLEA Japan HFD-32: fat (powdered tallow and safflower oil of high oleic type) 32.0%, protein 25.5%, fiber 2.9%, mineral 4.0%, nitrogen 29.4%, water 6.2%) starting from 8 wk of age for 18 wk. Mice were weighed weekly. The ingredients of HFD-32 are listed in detail at ,http://www.cleajapan.com/Feed/pdf/clea_hfd32.pdf.. Major fatty acids included oleic acid (C 18:1 ; 64.3%), palmitic acid (C 16:0 ; 12.6%), linoleic acid (C 18:2 ; 10.2%), and stearic acid (C 18:0 ; 7.5%). After 18 wk of feeding, mice were sacrificed for analysis. For some experiments, mice were injected intraperitoneally with a-GalCer (0.1 mg/g body weight, BW) or vehicle as control to examine the change of BW.
Blood chemistry
Total cholesterol (T-chol), high-density lipoprotein (HDL) cholesterol (HDL-chol), triglyceride (TG), and alanine aminotransferase (ALT) concentrations in sera were quantified by colorimetric assays with the Fuji Drychem system (Fujifilm Medical, Osaka, Japan) according to the manufacturer's protocol, as described elsewhere [16] .
Histology and quantitative analyses of microscopic images
Perigonadal fat tissue was removed and fixed with buffered formaldehyde solution (10%) followed by ordinary processing for paraffin-embedded sections and hematoxylin-eosin (HE) staining. Images of the HE-stained adipose tissue were incorporated with a BIOREVO microscope (BZ8100; Keyence Corp., Osaka, Japan), and morphometric analyses were performed with image analysis software (BZ-H2A, -H1C) equipped on the microscope. Liver samples were snap-frozen in OCT compound (Sakura Finetek Co., Tokyo, Japan) with liquid nitrogen, and cryosections were stained with Oil Red O (ORO) (Sigma Chemical Co., St. Louis, MO) and Meyer's hematoxylin (Wako Pure Chemical Co. Ltd., Osaka, Japan). Images of lipid droplets in hepatocytes stained red were quantified by computerized image analysis system (Scion Image software, Scion Corp., Frederick, MD).
Flow cytometry
Splenocytes were prepared by mincing the spleen with a glass homogenizer, and red blood cells were lysed with Tris-NH 4 Cl solution. Hepatic mononuclear cells (HMNC) were isolated from liver homogenates by density-gradient centrifugation with 33% Percoll TM (GE Healthcare Life Sciences, Piscataway, NJ) as previously reported [22] . Stromal vascular cells were isolated from the digest of perigonadal fat by mincing and incubating with collagenase D solution (2 mg/ml) (Roche Diagnostics, Indianapolis, IN) for 1-1.5 h. The cells were incubated with 2.4G2 monoclonal antibody (mAb) (anti-FccRIII/II) to block nonspecific binding of primary mAb and then reacted with CD1d:Ig recombinant fusion protein (BD Biosciences Pharmingen, San Diego, CA) loaded with a-GalCer (a-GalCer-CD1d-dimer), followed by detection with phycoerythrin (PE)-conjugated antimouse IgG 1 mAb (A85-1; BD) according to the manufacturer's protocol [16] . After washing, cells were stained with a combination of the following mAb conjugates: fluorescein isothiocyanate (FITC)-anti-TCRb chain (H57-597; BD), -anti-CD3e (145-2C11; BD), -anti-CD1d (1B1; BD), -anti-CD206 (MR5D3; BioLegend, San Diego, CA), -rat IgG 2a (BD), -rat IgG 2b (BD), allophycocyanin (APC)-anti-NK1.1 (PK136; BD, BioLegend), -anti-CD11c (HL3; BD), -Streptavidin (BioLegend), PE-anti-CD4 (RM4-5; BD), -anti-CD8 (53-6.7; BD), -anti-CD11b (M1/70; BioLegend), and APCCy7-Streptavidin (BD). Stained cells were acquired with FACS Calibur or Canto II flow cytometers (BD Bioscience Immunocytometry Systems, San Jose, CA) and analyzed with CellQuest, FACS Diva (BDIS), or FlowJo (Tommy Digital Biology, Tokyo, Japan) software as described elsewhere [16] . Propidium iodide (PI; Sigma) or 7-aminoactinomycin D (7-AAD; BD) positive cells were electronically gated as dead cells from the analysis.
Quantification of serum cytokines and adipokines
The concentration of Th1/Th2 and inflammatory cytokines, including IFN-c, tumor necrosis factor (TNF)-a, IL-1a, 2, 4, 5, 6, 10, 17, and GM-CSF in serum was quantified with Mouse Th1/ Th2 10plex FlowCytomix TM Multiplex (Bender MedSystems GmbH, Vienna, Austria) according to the manufacturer's protocol with a flow cytometer. Leptin (Morinaga Institute of Biological Sciences, Kanagawa, Japan) in sera was respectively quantified with enzyme-linked immunosorbent assay (ELISA) kit according to the manufacturers' protocol.
IPGTT and insulin tolerance test
Intraperitoneal (i.p.) glucose tolerance test (IPGTT) was performed by i.p. injection of glucose solution (1 g/kg) after 16 h of fasting [6] . The insulin tolerance test (ITT) was performed by i.p. injection of insulin (0.751U/kg; Humulin R 100 U/ml; Eli Lilly Japan KK, Kobe, Japan) after 3.5 h of fasting. The blood glucose level was serially quantified with a blood glucose monitor (MEDISAFE MINI; Terumo Corp., Tokyo, Japan). The insulin level was also quantified with the mouse insulin ELISA kit (Morinaga) according to the manufacturer's protocol.
HMNC transfer
HMNC were obtained from either Ja18 /well) obtained from perigonadal adipose tissue were cultured in RPMI medium (supplemented with 10% heatinactivated fetal calf serum, 100 U/ml penicillin, 100 mg/ml streptomycin, and 50 mM b-mercaptoethanol) with 1 mg/ml LPS for 20 h. After 20 h, supernatants were collected and frozen at 280uC, and cytokines were later quantified as described above.
Statistical analysis
Results were demonstrated as means 6 standard deviation (s.d.). Statistical analysis between two groups was performed by Student's t-test and among three groups was performed using ANOVA followed by Tukey-Kramer tests. Pearson's correlation coefficient test was used to examine the correlation. Values with P,0.05 were considered statistically significant.
Results
Impact of the presence of NKT cells on the weight gain of mice fed an HFD
Female or male B6 (WT), B6.Ja18 2/2 (Ja18 2/2 ), and B6.CD1d 2/2 (CD1d 2/2 ) mice were fed either an SFD or an HFD from 8 wk to 22,26 wk of age (for 14,18 wk), and the BW of each group of mice was plotted over time. Three groups of female ( Figure 1A ) or male ( Figure 1B ) mice showed a similar and gradual increase of BW when fed an SFD. On the other hand, all groups of female and male mice gained substantially more BW on HFD than those on SFD. However, CD1d 2/2 mice showed significantly less gains than those of WT and Ja18 2/2 mice ( Figure 1A, B) . Consistently, the least difference was observed in CD1d 2/2 mice when the net gain ([BW on HFD at n wk]2[BW on HFD at 8 wk]: n$8 wk) was compared ( Figure 1C, D) . We also compared BW in WT mice that received either the prototypical type I NKT cell ligand a-GalCer or vehicle when fed either an SFD or an HFD. There was no significant difference in weight gain between mice that received a-GalCer or vehicle and fed either an SFD or an HFD ( Figure S1A ), suggesting that type I NKT cells might have a minimal role in the development of DIO even when the activating ligand is provided.
When the daily food intake per animal was compared in each group of mice by calculating S[(amounts given2amounts left)/ total periods] throughout the feeding periods, CD1d 2/2 female mice took in slightly smaller amounts of both SFD and HFD than the other two strains, WT and Ja18 2/2 mice ( Figure 2A ). A similar tendency in food intake was observed in male mice (data not shown).
The BW of CD1d 2/2 mice was significantly lower than that of WT and Ja18 2/2 mice after 18 wk of HFD feeding ( Figure 2B ) (WT = Ja18 ). The difference in BW in each group of mice was attributable to the sum of the differences in weights of organs and tissues. Thus, the liver, perigonadal fat tissue (white adipose tissue; WAT) and fat tissue between the scapulae (brown adipose tissue; BAT) of each group were obtained and compared. Consistent with the differences in BW, CD1d 2/2 mice had lower liver weight ( Figure 2C ) (WT = Ja18 ), when compared to those of sex-matched WT or Ja18 2/2 mice fed an HFD (closed bar). In SFD-fed mice, there were no significant differences in the weights of the whole BW, liver, WAT, and BAT among the three groups of mice (Figure 2B -E; open bar).
When serum lipids were quantified in the three groups of mice fed an HFD, WT and Ja18 2/2 mice exhibited significantly higher levels of T-chol-and HDL-chol than CD1d 2/2 mice ( Figure S2A , B). The cholesterol level was consistent with the extent of adiposity, whereas the TG level was not different among the three groups ( Figure S2C ).
HFD-induced hepatosteatosis and adipocyte hypertrophy are ameliorated in CD1d
2/2 mice First, livers were histologically examined for major causes of weight gain among three strains of mice on HFD. WT and Ja18 2/2 mice on HFD had marked hepatosteatosis, which was revealed by red deposits on ORO staining ( Figure 3A) . On the other hand, livers of CD1d 2/2 mice that appeared less fatty exhibited lighter deposits on ORO staining ( Figure 3A) . The ORO-positive regions in CD1d 2/2 livers were significantly smaller than those of WT and Ja18 2/2 mice ( Figure 3B ). The severity of steatosis appeared consistent with the liver weight and dyslipidemic level in each strain (Figure 2A and B) . Furthermore, the ALT level, a marker of liver damage, was significantly suppressed in CD1d 2/2 mice ( Figure 3C ). We also quantified pro-inflammatory cytokines that were secreted from HMNC in mice fed an HFD upon stimulation with LPS. Production of IL-6 and TNF-a in culture supernatants was increased in WT and Ja18 2/2 mice, whereas it was suppressed in HMNC cultures of CD1d 2/2 mice ( Figure 3D , E). Thus, lipidinduced inflammation may be suppressed in the absence of CD1d and CD1d-restricted NKT cells.
Next, we similarly analyzed adipose tissues that also contribute to the difference in BW in the three groups of mice. CD1d 2/2 mice had apparently smaller adipocytes in adipose tissue even on HFD, whereas enlarged adipocytes occupied the entire tissue in WT and Ja18 2/2 mice ( Figure 4A ). Of note, boundaries of adipocytes formed almost straight lines due to the close packing of adipocytes in WT mice ( Figure 4A left panel) . To compare adipocyte size in WAT of each group of mice, the circumference of each adipocyte was morphometrically compared ( Figure 4B ). The adipocytes from CD1d 2/2 mice had significantly smaller circumference than those from WT and Ja18 2/2 mice. When leptin is overexpressed, mice demonstrate a lean phenotype [23] . To examine whether CD1d 2/2 expressed a higher level of leptin in sera than WT and Ja18 2/2 mice, serum leptin levels were quantified. However, CD1d 2/2 showed the lowest level among the three strains of mice, which was proportional to the volume of WAT ( Figure 4C ).
Analysis of infiltrated cellular components in liver of mice fed an HFD
Our findings thus far showed that adiposity and hepatosteatosis were similar between WT and Ja18 2/2 but were minimal in CD1d 2/2 mice. The difference between Ja18 2/2 and CD1d
mice is solely the absence of type II NKT cells selected by CD1d in CD1d 2/2 but not Ja18 2/2 mice. To study the relationship between type I (iNKT) and type II NKT cells, we analyzed NKT cell subsets in liver and adipose tissue of each strain. As shown in our previous report with the short term feeding of HFD [18] , the proportion of NKT cells in liver decreased in WT mice fed an HFD compared to mice on an SFD when the HMNC fraction was stained with a combination of either a-GalCer-loaded CD1d-dimer and anti-TCRb mAb (iNKT cells) ( Figure 5A-a, b; 22.8%2.6.8%) or anti-NK1.1 and TCRb mAb (total NKT cells, including NKT-like cells) ( Figure 5A-c, d ; 27.9%2.6.6%). To detect the subset of type II NKT cells and NKT-like cells in the iNKT cell-deficient strains, the latter combination was employed. Although a significant decrease was demonstrated in NKT cells in WT mice (Figure 5B-a) , there was no significant difference in the proportion of total NKT cells in Ja18 2/2 and CD1d 2/2 mice fed an HFD ( Figure 5B-a) , but Ja18 2/2 mice appeared to exhibit a slight decrease in the prevalence of these cells on an HFD. To examine the residual NKT-like cells in the livers of Ja18 2/2 and CD1d 2/2 mice, staining with a combination of anti-NK1.1 and anti-TCRb mAb was employed. As demonstrated in the FACS profiles, total NKT cells in WT mice were significantly decreased after HFD feeding ( Figure 5B-a) . As for the subset of residual NKT cells, the subset that expressed neither CD4 nor CD8 (CD4 Figure 5B-b, c) . Although the total number of liver NKT cells was reduced, the residual population was mainly a CD4 + subset in WT mice and the remaining cells were a CD4 
Analysis of infiltrated cellular components in adipose tissue of mice fed an HFD
The SVF in adipose tissue contains innate lymphocytes and Mw even under normal conditions. In adipose tissue in obese mice, we 
.2%). The percentage of NKT cells increased in WT and Ja18
2/2 cells when the NKT cells of mice on HFD were compared with those on SFD (WT; p,0.05; Ja18 2/2 ; p,0.01), whereas such an increase was not observed in CD1d 2/2 mice ( Figure 6B -a). Since CD1d 2/2 mice lack CD4 + CD1d-restricted NKT cells, there were significant differences in the percentages ( Figure 6B -b) (WT; p,0.05; Ja18 2/2 ; p,0.01) and actual cell numbers (WT, Ja18 2/2 ; p,0.05). Of note, the CD8 + subset was prominently increased in the adipose tissue of Ja18 2/2 mice both in percentage ( Figure 6B -c) and in number. The CD4 2 8 2 subset of NKT cells appeared to be significantly decreased in Ja18 2/2 mice fed an HFD, most likely due to the relative abundance of the CD4 2 8 + subset (Figure 6B-d) . Similar results were obtained when analyzing actual cell numbers (WT.Ja18 2/2 .CD1d 2/2 ) (data not shown). We analyzed and compared the proportion of NKT cells at early and late phases (18-wk) of HFD feeding. In WT mice, the number of a-GalCer-CD1d-dimer + cells and NK1.1 + TCRb + cells in liver were increased at 1 wk of HFD-feeding, and numbers tended to decrease thereafter ( Figure S3A ). On the other hand, these cells, especially the NK1.1 + TCRb + population, were gradually increased in adipose tissue ( Figure S3B ). The increase in NK1.1
+
TCRb
+ cells (percentage in SVF) in adipose tissue correlated with BW in WT and Ja18 2/2 mice, whereas no correlation was found in CD1d 2/2 mice ( Figure 6C ). A similar correlation was obtained between numbers of NK1.1 + TCRb + cells (cell number/g adipose tissue) and BW (data not shown).
Analysis of MQ in adipose tissue and cytokine production upon LPS stimulation
MQ are another major cellular subset in SVF and may affect the metabolism of adipose tissue. Therefore, SVF preparations from the three strains of mouse were stained with F4/80 and CD11b ( Figure 7A ). The three strains had a similar pattern of F4/80
+ staining. Although we anticipated that CD1d 2/2 mice had fewer MQ than Ja18 2/2 mice, the percentage of F4/80
+ cells in CD1d 2/2 mice was higher than that of Ja18 2/2 mice ( Figure 7B-a) . However, when the F4/80 + population was divided into two subpopulations according to the MFI of F4/80 staining pattern, i. e., Population 1 (P1: F4/80 high ) and Population 2 (P2: F4/80 low,2 ) cells (both CD11b + ), WT mice had higher frequencies of P1 than Ja18 2/2 mice ( Figure 7B-b) , whereas CD1d 2/2 mice had an increased frequency of P2 than WT and Ja18 2/2 mice ( Figure 7B-c) . Analyses of actual cell numbers demonstrated the same tendency among the three mouse strains (data not shown). Of note, a higher MFI of CD1d expression was detected in the cells of the P1 population compared with the P2 population, both in WT and Ja18 2/2 mice ( Figure 7C-a, b, c) . To examine functional differences in a specific Mw population, total cells from the SVF fraction were stimulated with LPS for 20 h and cytokines were measured (Figure 8 ). IL-10 levels were significantly higher in SVF cultures from CD1d 2/2 mice compared with WT mice (Figure 8A ), and GM-CSF was significantly lower in Ja18 2/2 and CD1d 2/2 mice ( Figure 8B) . Notably, the production of TNF-a in the culture supernatant that could affect insulin resistance was not significantly different among the three strains ( Figure 8C ).
Glucose and insulin tolerance are ameliorated CD1d
2/2 mice
Since the pattern of adiposity should reflect levels of glucose intolerance, IPGTT was performed in the three mouse strains (Figure 9) . No difference was observed in fasting blood sugar levels and in elevation after i.p. administration of glucose over time in the three strains fed an SFD ( Figure 9A, left) . On the other hand, CD1d 2/2 mice demonstrated the lowest fasting blood sugar level and a suppressed elevation profile after glucose administration among the three strains on an HFD (Figure 9A, right) . Insulin levels were significantly higher in WT and Ja18 2/2 mice before and at 120 min after infusion than that obtained in the respective groups on an SFD (data not shown) and for CD1d 2/2 mice on an HFD, suggesting that insulin resistance was present in those strains ( Figure 9B ). To further examine insulin resistance, an ITT was performed in HFD-fed mice that had been fasted for 3.5 h [6] ( Figure 9C ). Following injection of insulin, blood glucose levels fell most prominently in CD1d 2/2 mice at 30 and 60 min after the injection ( Figure 9C ). The decrease in glucose level in WT mice injected with a-GalCer was less than that of mice injected with vehicle ( Figure S1B ), suggesting that insulin resistance was reproduced in mice when iNKT cells were activated [18] , although there was no net increase in BW with the treatment. Thus, CD1d 2/2 mice developed the least resistance to insulin in the absence of both iNKT and type II NKT cells.
To examine whether type II NKT cells alone could reproduce the pathophysiological status observed in Ja18 2/2 mice, HMNC obtained from either Ja18 2/2 or CD1d 2/2 mice were intravenously transferred to CD1d 2/2 recipient mice and weight gain was examined on an HFD. CD1d 2/2 mice that received HMNC from Ja18 2/2 mice showed a slight increase in BW and exhibited a less profound decrease in blood glucose levels in the ITT ( Figure  S4A, C) . Although no significant difference was detected with the IPGTT (Figure S4B ), CD1d 2/2 mice that received HMNC from 
Ja18
2/2 mice showed higher insulin resistance than CD1d
mice that received HMNC from CD1d 2/2 mice. The percentage of NKT cells (NK1.1 + TCRb + ) and CD4 + NKT cells was similar in the liver and adipose tissue of CD1d 2/2 hosts ( Figure S4D-a, b) . However, CD8
+ NK1.1 + T cells in adipose tissue were significantly increased in mice transferred with HMNC from Ja18 2/2 -mice ( Figure S4D-c) , similarly to what we observed in Ja18 2/2 mice fed an HFD.
Discussion
Adipocytes, MQ and T cells are now thought to constitute a functional triad to promote obesity and obesity-associated disorders [1] [2] [3] [6] [7] [8] . Recently, the involvement of eosinophils and B cells has also been demonstrated [24, 25] , implying that many other immune cells participate in the physiologic and pathologic processes of adipocyte hypertrophy. This may be a natural process since adipose tissue is thought to be an ancestor of lymphoid organs [5, 14] .
In the present study, we demonstrated that an innate lymphocyte of the T cell lineage, the CD1d-restricted NKT cell, also has an active role in the development of obesity. When fed an HFD (CLEA Japan), CD1d 2/2 mice gained the least weight compared to Ja18 2/2 and WT mice. This difference was demonstrated when mainstream CD8 + T cells were primarily unaffected. Furthermore, similar results were obtained with different types of HFD (Harlan Teklad [26] and our own original preparation [18] ), suggesting that the suppression of weight gain was solely dependent on the deficiency of CD1d-restricted NKT cells but not on the specific source of fat, i.e. fatty acid composition.
Since Ja18 2/2 mice gained comparable BW as WT mice, the residual CD1d-restricted, type II NKT cells appeared to contribute to the accumulation of visceral fat in the body. In HFD-fed WT and Ja18 2/2 mice, the number of NK1.1 + TCRb + cells increased along with the hypertrophic change of abdominal WAT (Figure 4, 6 ), whereas the a-GalCer-CD1d dimer + population did not change in adipose tissue of WT mice, suggesting that the type II NKT cells were the major population affecting adipose tissue metabolism. Accordingly, the transfer of NKT cells from Ja18 2/2 mice to CD1d 2/2 mice resulted in weight gain and significant increase in insulin resistance ( Figure  S4 as well as in WT mice, whereas no correlation was found in CD1d 2/2 mice ( Figure 6C ). When the NK1.1 + TCRb + cells in adipose tissue were analyzed, we were unable to detect these cells with sulfatide-loaded CD1d-multimers that are specific for a subset of type II NKT cells [27] (data not shown). Of note, these cells exhibited a biased repertoire in specific Vbs in HFD-fed WT mice (data not shown), although the significance of this finding remains unclear. It should also be noted that a-GalCer administration did not boost weight gain in WT mice fed an HFD, although insulin action was blunted with a-GalCer administration. This result indicated that insulin resistance but not adiposity could be reproduced through the activation of type I NKT cells ( Figure  S1A ).
Nishimura et al demonstrated that CD8 + T cells are important for recruitment of Mw and chronic inflammation in adipose tissue, which was proposed to propagate inflammation [6] . In our experiments, the CD8 + subset of NK1.1 + T cells, a rather rare subset [28] , increased in adipose tissue in WT and Ja18 2/2 mice. Although we have not analyzed TCR Vb chain usage, Nishimura described them as Vb7 and Vb10b [6] . Since Vb7 is one of the preferred Vb chains of NKT cells [29] , it is possible that these cells or a portion of these cells include NKT cells. Very recently, Mantell et al. reported that no protection against metabolic abnormalities was noted in CD1d 2/2 mice fed an HFD [30] . They demonstrated no significant differences between WT and CD1d 2/2 mice in physiologic, metabolic, and inflammatory parameters. Nevertheless, since there was an early and reversible decrease in liver NKT cells, mice appeared to respond to an HFD. Specific reasons for these divergent findings will need to be explored in future studies. One possibility might be the colonization of mice from different animal facilities with different flora. An important role of intestinal flora in the process of obesity has emerged [31] , and the differential dominance of certain species of microbes has been demonstrated in obese or anorexic human individuals [32] . Furthermore, in toll-like receptor 5 knockout (TLR5 2/2 ) mice, metabolic syndrome was induced by altered gut microbiota with hyperphagic traits [33] . Moreover, these metabolic changes could be conferred to WT, germ-free mice upon transfer of the gut microbiota derived from TLR5 2/2 mice. Although adaptive immunity is not directly related to the process of obesity in TLR5 2/2 mice, it should be noted that the development of adiposity could be controlled by balancing the complex microbiota. Since bacterial colonization in the intestine is regulated by a CD1d-dependent, NKT cell-mediated mechanism [34] , it is possible that NKT cell deficiency may alter the intestinal flora, and thus influence either an adipogenic or anti-adipogenic host milieu.
The recruitment of Mw towards visceral fat, also known as adipose tissue Mw (ATMw; CD11b + F4/80 + ), has also been thought to be a hallmark of obesity [1, 2] . The F4/80 + fraction can be subdivided into the F4/80 high and F4/80 low populations [35] . In the present study, ATMw of WT and Ja18 2/2 mice had an increased F4/80 high population, whereas CD1d 2/2 mice predominantly had an increased percentage and number of the The present study suggests that type II NKT cells may serve as a potential target for controlling the volume of visceral fat and insulin resistance. A possible approach may be the administration of a CD1d-binding ligand to modulate NKT cell function. Indeed, Ilan's group has demonstrated that the administration of glucocerebroside (b-glucosylceramide; b-GlcCer) or the direct transfer of NKT cells ameliorated metabolic aberration and steatohepatitis of leptin-deficient ob/ob mice [38, 39] . They demonstrated that the therapeutic effects of b-GlcCer were associated with a Th2-shift (decreased IFN-c and increased IL-10) and the redistribution of NKT cells in the liver to the periphery. Furthermore, b-GlcCer modulated the lipid rafts of NKT cells, thus altering the expression of molecules of cellular signaling, such as flotillin-2, Lck, and STAT1 [40] . Although the mode of action appears to be dependent on iNKT cells, it remains possible that these CD1d-binding non-stimulatory ligands may simply function as antagonists for all CD1d-restricted NKT cells.
Of special interest, Lynch et al. demonstrated that NKT cells and CD1d
+ cells are abundantly detected in the omentum tissue in humans [41] . Half of the NKT (CD3 + CD56 + ) cells stained with the 6B11 mAb [42] , indicating that they were iNKT cells, but the remaining cells likely are type II NKT cells. They also reported a net decrease of iNKT cells in severely obese individuals with a relative increase of CD56 + T cells (healthy, 49.9%; obese, 61.9%) and discussed that the relative immunocompromised status in obesity due to the decreases in iNKT cells might be related to sensitivity to infections [40] . On the other hand, the omentum may be a source of not only iNKT cells but also type II NKT cells that are capable of inducing adiposity in the abdominal cavity.
In conclusion, we showed that deficiency of CD1d-resricted NKT cells suppressed the development of obesity, likely because inflammation of adipose tissue and liver were ameliorated and reduced levels of insulin resistance were induced. NKT cells, especially the type II subset, may be the initial subset of T cells that recognizes and responds to lipid excess. Thus, CD1d-restricted, type II NKT cells may be a novel target for therapeutic intervention in the metabolic syndrome. Searching for regulatory ligands and novel ways of regulation that include the selective elimination of pathogenic type II NKT cells might permit the control of not only metabolic syndrome but also various diseases related to lipid inflammation mediated by NKT cells [43] . 
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